Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global IVD Infectious Diseases Market Status and Forecast (2016-2027)
  • 1.3.2 Global IVD Infectious Diseases Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global IVD Infectious Diseases Supply by Company

• 2.1 Global IVD Infectious Diseases Sales Value by Company
• 2.2 IVD Infectious Diseases Sales Area of Main Manufacturers
• 2.3 Trend of Concentration Rate

3 Global and Regional IVD Infectious Diseases Market Status by Category

• 3.1 IVD Infectious Diseases Category Introduction
  • 3.1.1 Immunochemistry
  • 3.1.2 Molecular Diagnostics
• 3.2 Global IVD Infectious Diseases Market by Category
• 3.3 North America: by Category
• 3.4 Europe: by Category
• 3.5 Asia Pacific: by Category
• 3.6 Central & South America: by Category
• 3.7 Middle East & Africa: by Category

4 Global and Regional IVD Infectious Diseases Market Status by End User/Segment

• 4.1 IVD Infectious Diseases Segment by End User/Segment
  • 4.1.1 Clinical Laboratories
  • 4.1.2 Diagnostic Centers
• 4.2 Global IVD Infectious Diseases Market by End User/Segment
• 4.3 North America: by End User/Segment
• 4.4 Europe: by End User/Segment
• 4.5 Asia Pacific: by End User/Segment
• 4.6 Central & South America: by End User/Segment
• 4.7 Middle East & Africa: by End User/Segment

5 Global IVD Infectious Diseases Market Status by Region

• 5.1 Global IVD Infectious Diseases Market by Region
• 5.2 North America IVD Infectious Diseases Market Status
• 5.3 Europe IVD Infectious Diseases Market Status
• 5.4 Asia Pacific IVD Infectious Diseases Market Status
• 5.5 Central & South America IVD Infectious Diseases Market Status
• 5.6 Middle East & Africa IVD Infectious Diseases Market Status

6 North America IVD Infectious Diseases Market Status

• 6.1 North America IVD Infectious Diseases Market by Country
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe IVD Infectious Diseases Market Status

• 7.1 Europe IVD Infectious Diseases Market by Country
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific IVD Infectious Diseases Market Status

• 8.1 Asia Pacific IVD Infectious Diseases Market by Country
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America IVD Infectious Diseases Market Status

• 9.1 Central & South America IVD Infectious Diseases Market by Country
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa IVD Infectious Diseases Market Status

• 10.1 Middle East & Africa IVD Infectious Diseases Market by Country
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Major Downstream Customers Analysis

• 11.1 Customer One Analysis
• 11.2 Customer Two Analysis
• 11.3 Customer Three Analysis
• 11.4 Customer Four Analysis

12 Global IVD Infectious Diseases Market Forecast by Category and by End User/Segment

• 12.1 Global IVD Infectious Diseases Sales Value Forecast (2022-2027)
• 12.2 Global IVD Infectious Diseases Forecast by Category
• 12.3 Global IVD Infectious Diseases Forecast by End User/Segment

13 Global IVD Infectious Diseases Market Forecast by Region/Country

• 13.1 Global IVD Infectious Diseases Market Forecast by Region (2022-2027)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 BD
  • 14.1.1 Company Information
  • 14.1.2 IVD Infectious Diseases Product Introduction
  • 14.1.3 BD IVD Infectious Diseases Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.1.4 SWOT Analysis
• 14.2 Sysmex
  • 14.2.1 Company Information
  • 14.2.2 IVD Infectious Diseases Product Introduction
  • 14.2.3 Sysmex IVD Infectious Diseases Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.2.4 SWOT Analysis
• 14.3 Siemens Healthcare
  • 14.3.1 Company Information
  • 14.3.2 IVD Infectious Diseases Product Introduction
  • 14.3.3 Siemens Healthcare IVD Infectious Diseases Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.3.4 SWOT Analysis
• 14.4 Roche Diagnostics
  • 14.4.1 Company Information
  • 14.4.2 IVD Infectious Diseases Product Introduction
  • 14.4.3 Roche Diagnostics IVD Infectious Diseases Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.4.4 SWOT Analysis
• 14.5 Quidel
  • 14.5.1 Company Information
  • 14.5.2 IVD Infectious Diseases Product Introduction
  • 14.5.3 Quidel IVD Infectious Diseases Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.5.4 SWOT Analysis
• 14.6 Qiagen
  • 14.6.1 Company Information
  • 14.6.2 IVD Infectious Diseases Product Introduction
  • 14.6.3 Qiagen IVD Infectious Diseases Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.6.4 SWOT Analysis
• 14.7 Orasure
  • 14.7.1 Company Information
  • 14.7.2 IVD Infectious Diseases Product Introduction
  • 14.7.3 Orasure IVD Infectious Diseases Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.7.4 SWOT Analysis
• 14.8 Hologic
  • 14.8.1 Company Information
  • 14.8.2 IVD Infectious Diseases Product Introduction
  • 14.8.3 Hologic IVD Infectious Diseases Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.8.4 SWOT Analysis
• 14.9 Gen-Probe
  • 14.9.1 Company Information
  • 14.9.2 IVD Infectious Diseases Product Introduction
  • 14.9.3 Gen-Probe IVD Infectious Diseases Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.9.4 SWOT Analysis
• 14.10 Danaher
  • 14.10.1 Company Information
  • 14.10.2 IVD Infectious Diseases Product Introduction
  • 14.10.3 Danaher IVD Infectious Diseases Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.10.4 SWOT Analysis
• 14.11 Cepheid
• 14.12 Bio-Rad Laboratories
• 14.13 BioMerieux
• 14.14 Abbott
• 14.15 Abbott

15 Conclusion

16 Methodology

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global IVD Infectious Diseases market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global IVD Infectious Diseases market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Immunochemistry
Molecular Diagnostics

Segmented by End User/Segment
Clinical Laboratories
Diagnostic Centers

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
BD
Sysmex
Siemens Healthcare
Roche Diagnostics
Quidel
Qiagen
Orasure
Hologic
Gen-Probe
Danaher
Cepheid
Bio-Rad Laboratories
BioMerieux
Abbott
Abbott